Videocapillaroscopic pattern of alopecia areata before and after diphenylciclopropenone treatment

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 4, 2011, Pages 1087-1091

  Ganzetti, Giulia ^a   Campanati, A ^a   Simonetti, O ^a   Cataldi, I ^a   Giuliodori, K ^a   Offidani, A M ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Alopecia areata; DPCP; Videocapillaroscopy

Indexed keywords

DIPHENCYPRONE;

ADULT; ALOPECIA AREATA; ANGIOGENESIS; ARTICLE; CAPILLAROSCOPY; CLINICAL ARTICLE; CONTACT DERMATITIS; DRUG EFFICACY; DRUG SAFETY; DRUG SENSITIZATION; EPILUMINESCENCE MICROSCOPY; FEMALE; HAIR FOLLICLE; HAIR GROWTH; HUMAN; IMAGE ANALYSIS; MALE; PRIORITY JOURNAL; SCALP HAIR; TREATMENT DURATION; TREATMENT RESPONSE; ACUTE CONTACT DERMATITIS; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; DERMATOSCOPE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG WITHDRAWAL; GOLD STANDARD; PROGNOSIS; SKIN EXAMINATION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VIDEOCAPILLAROSCOPY; VIDEODERMATOSCOPY;

EID: 84856586585     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400428     Document Type: Article

References (15)

1. Randall VA. Is alopecia areata an autoimmune disease? Lancet 2001; 358:1922-23.
2. McDonagh AJG, Messenger AG. The pathogenesis of alopecia areata. Dermatol Clin 1996; 14:661-70. (Pubitemid 26322534)
3. Messenger AG, Slater DN, Bleehen SS. Alopecia areata: alterations in the hair growth cycle and correlation with the follicular pathology. Br J Dermatol 1986; 114:337-47. (Pubitemid 16124178)
4. McDonald-Hull SP, Wood ML, Hutchinson PE, et al. Guidelines for the management of alopecia areata. Br J Dermatol 2003; 149:692-99. (Pubitemid 37419985)
5. Ross EK, Vincenzi C, Tosti A. Videodermoscopy in the evaluation of hair and scalp disorders. J Am Acad Dermatol 2006; 55:799-806. (Pubitemid 44556832)
6. Rudnicka L, Olszewska M, Rakowska A, et al. Trichoscopy: a new method for diagnosing hair loss. J Drug Dermatol 2008; 7:651-4.
7. Happle R, Hausen BM, Wiesner Menzel L. Diphencyprone in the treatment of alopecia areata. Acta Derm Venereol (Stockh) 1983; 63:49-52. (Pubitemid 13172544)
8. Aghaei S, Ardekani GS. Topical immunotherapy with diphenylcyclopropenone in vitiligo. A preliminary experience. Indian J Dermatol Venereol Leprol 2008; 74:628-31.
9. Hardy MH. The secret life of the hair follicle. Trends Genet 1992; 8:55-60.
10. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219:983-85.
11. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246:1306-9. (Pubitemid 20066716)
12. Herbst V, Zoller M, Kissling S et al. Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes. Eur J Dermatol 2006; 16:537-42. (Pubitemid 44861829)
13. Goldman CK, Tsai JC, Roroceanu L, et al. Loss of vascular endothelial growth factor in human alopecia areata hair follicles. J Invest Dermatol 1995; 104(S):18-20.
14. Simonetti O, Lucarini G, Bernardini ML, et al. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study. Br J Dermatol 2004;150:940-48. (Pubitemid 38903527)
15. Inui S, Nakajima T, Nagakawa K, et al. Clinical significance of dermoscopy in alopecia areata: analysis of 300 cases. Int J Dermatol 2008; 47:688-93. (Pubitemid 352016080)